Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pedersen

Showing results (21-30 of 1,899) with videos related to

Pageof 190
Sort By:
Ugeskrift for Laeger|September 22, 1975
[Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension]O L Pedersen
Ugeskrift for Laeger|September 22, 1975
[Abstinence symptoms on sudden withdrawal of beta receptor blocking therapy]O L Pedersen
Journal of Bioenergetics and Biomembranes|March 3, 2012
3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issuePeter L Pedersen
Journal of Bioenergetics and Biomembranes|August 29, 2012
Mitochondria in relation to cancer metastasis: introduction to a mini-review seriesPeter L Pedersen
Lancet (London, England)|September 9, 1989
Hymenoptera stings and beta-blockersD L Pedersen
Journal of Bioenergetics and Biomembranes|June 11, 2009
Mitochondrial matters of the heart: a plethora of regulatory modes to maintain function for a long lifetimePeter L Pedersen
Danish Medical Bulletin|July 29, 2000
Inflammatory pain in experimental burns in manJ L Pedersen
Ugeskrift for Laeger|February 13, 1978
[Drug information. Timolol]O L Pedersen
Annals of the New York Academy of Sciences|January 1, 1982
H+-ATPases in biological systems: an overview of their function, structure, mechanism, and regulatory propertiesP L Pedersen
Journal of Bioenergetics and Biomembranes|September 20, 2007
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygenPeter L Pedersen
Pageof 190

Showing results (21-30 of 1,899) with videos related to

Sort By:
Pageof 190
Ugeskrift for Laeger|September 22, 1975
[Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension]O L Pedersen
Ugeskrift for Laeger|September 22, 1975
[Abstinence symptoms on sudden withdrawal of beta receptor blocking therapy]O L Pedersen
Journal of Bioenergetics and Biomembranes|March 3, 2012
3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issuePeter L Pedersen
Journal of Bioenergetics and Biomembranes|August 29, 2012
Mitochondria in relation to cancer metastasis: introduction to a mini-review seriesPeter L Pedersen
Lancet (London, England)|September 9, 1989
Hymenoptera stings and beta-blockersD L Pedersen
Journal of Bioenergetics and Biomembranes|June 11, 2009
Mitochondrial matters of the heart: a plethora of regulatory modes to maintain function for a long lifetimePeter L Pedersen
Danish Medical Bulletin|July 29, 2000
Inflammatory pain in experimental burns in manJ L Pedersen
Ugeskrift for Laeger|February 13, 1978
[Drug information. Timolol]O L Pedersen
Annals of the New York Academy of Sciences|January 1, 1982
H+-ATPases in biological systems: an overview of their function, structure, mechanism, and regulatory propertiesP L Pedersen
Journal of Bioenergetics and Biomembranes|September 20, 2007
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygenPeter L Pedersen
Pageof 190